Cargando…
Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
PALB2 is an important BRCAx candidate for familial breast cancers (FBC). PALB2 pathogenic variants (PVs) may not to conform to “two hit” paradigm. However, a recent study demonstrates that in the majority PALB2 germline mutant breast cancers, the loss of heterozygosity (LOH) and somatic point mutati...
Autores principales: | Hu, Zhe-Yu, Liu, Liping, Xie, Ning, Lu, Jun, Liu, Zhentian, Tang, Yu, Wang, Yikai, Yang, Jianbo, Ouyang, Quchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482549/ https://www.ncbi.nlm.nih.gov/pubmed/33193564 http://dx.doi.org/10.3389/fgene.2020.00829 |
Ejemplares similares
-
Tumour morphology predicts PALB2 germline mutation status
por: Teo, Z L, et al.
Publicado: (2013) -
Case Report: Effectiveness of Targeted Treatment in a Patient With Pancreatic Cancer Harboring PALB2 Germline Mutation and KRAS Somatic Mutation
por: Wu, Wei, et al.
Publicado: (2022) -
Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients
por: Kwong, Ava, et al.
Publicado: (2021) -
Spectrum of PALB2 germline mutations and characteristics of PALB2‐related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next‐generation sequencing
por: Zhou, Jiaojiao, et al.
Publicado: (2020) -
Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance
por: Horak, Peter, et al.
Publicado: (2019)